Cencora

From Philadelphia.Wiki

Template:Infobox Company

Cencora (formerly AmerisourceBergen) is one of the world's largest pharmaceutical distribution companies, headquartered in Conshohocken, Pennsylvania, in the Philadelphia suburbs. Formed in 2001 through the merger of AmeriSource and Bergen Brunswig, the company (renamed Cencora in 2023) distributes pharmaceuticals, medical supplies, and healthcare products to pharmacies, hospitals, and healthcare providers across the United States and globally. As a Fortune 10 company with revenues exceeding $260 billion, Cencora is one of the Philadelphia region's largest corporations and a critical link in the pharmaceutical supply chain.[1]

History

AmeriSource Origins

Pre-merger:

  • AmeriSource roots to 1871
  • Allentown, PA based
  • Drug distribution
  • Regional growth

Bergen Brunswig

West Coast heritage:

  • Bergen Brunswig Corporation
  • California based
  • National distributor
  • Industry leader

Merger (2001)

Combination:

  • AmeriSource and Bergen Brunswig merged (2001)
  • AmerisourceBergen*** formed
  • Combined scale
  • National leader

Growth

Expansion:

  • Acquisitions
  • International expansion
  • Service development
  • Industry consolidation

Cencora Rebrand (2023)

New name:

  • Rebranded to Cencora*** (2023)
  • Modern identity
  • Global positioning
  • Stock ticker COR

Business Model

Pharmaceutical Distribution

Core business:

  • Distribute drugs to pharmacies
  • Hospital supply
  • Specialty pharmaceuticals
  • Generic and brand name

Scale

Operations:

  • One of three major U.S. distributors
  • Billions of doses annually
  • 50,000+ customer locations
  • National reach

Specialty Distribution

High-value drugs:

  • Oncology
  • Biologics
  • Complex therapies
  • Specialty pharmacies

Global Operations

International:

  • Multiple countries
  • Alliance Healthcare (UK, Europe)
  • World Courier (specialty logistics)
  • Global platform

Services

Distribution

Core:

  • Next-day delivery
  • Temperature control
  • Tracking
  • Compliance

Pharmacy Services

Support:

  • Inventory management
  • Consulting
  • Technology solutions
  • Business services

Manufacturer Services

Drug companies:

  • Commercialization
  • Patient access programs
  • Third-party logistics
  • Distribution agreements

Specialty Services

High-touch:

  • Patient support
  • Specialty pharmacy
  • Hub services
  • Clinical support

Philadelphia Region

Conshohocken Headquarters

Corporate base:

  • Montgomery County
  • Philadelphia suburbs
  • Modern campus
  • Major employer

Employment

Regional impact:

  • Thousands of employees
  • Corporate, distribution
  • Technology, operations
  • Career opportunities

Economic Impact

Scale:

  • Fortune 10 company
  • Major tax base
  • Supplier relationships
  • Economic multiplier

Industry Position

Big Three

Market structure:

  • Cencora
  • McKesson
  • Cardinal Health
  • Three dominate U.S. distribution

Market Share

Scale:

  • ~30% of U.S. market
  • Retail, hospital, specialty
  • Comprehensive coverage
  • National footprint

Challenges

Opioid Crisis

Legal exposure:

  • Litigation related to opioid distribution
  • Settlements
  • Industry-wide issue
  • Compliance focus

Regulation

Oversight:

  • DEA monitoring
  • State regulations
  • Drug safety requirements
  • Compliance costs

Competition

Market dynamics:

  • Consolidation pressure
  • Customer buying power
  • Manufacturer leverage
  • Margin pressure

Drug Pricing

Political:

  • Drug pricing debates
  • Policy uncertainty
  • Reform proposals
  • Industry scrutiny

Financial Performance

Revenue

Scale:

  • $260+ billion annually
  • Fortune 10
  • One of largest U.S. companies
  • Healthcare importance

Margins

Business economics:

  • Low-margin, high-volume
  • Distribution efficiency
  • Scale advantages
  • Service fees

Leadership

Corporate Governance

Structure:

  • Public company
  • Professional management
  • Board oversight
  • Industry veterans

Culture

Values:

  • Patient focus
  • Integrity
  • Compliance
  • Operational excellence

Future

Strategy

Direction:

  • Specialty growth
  • International expansion
  • Service development
  • Technology investment

Industry Trends

Outlook:

  • Specialty drug growth
  • Biosimilars
  • Healthcare consolidation
  • Value-based care

See Also

References

  1. "Cencora". Cencora. Retrieved December 31, 2025

External Links